Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, No. 88 Jiefang Road, Hangzhou, 310009, China.
Key Laboratory of The Diagnosis and Treatment of Severe Trauma and Burn of Zhejiang Province, Hangzhou, China.
Stem Cell Res Ther. 2022 Jul 15;13(1):313. doi: 10.1186/s13287-022-03000-0.
Acute compartment syndrome (ACS), a well-known complication of musculoskeletal injury, results in muscle necrosis and cell death. Embryonic stem cell-derived mesenchymal stem cells (ESC-MSCs) have been shown to be a promising therapy for ACS. However, their effectiveness and potentially protective mechanism remain unknown. The present study was designed to investigate the efficacy and underlying mechanism of ESC-MSCs in ACS-induced skeletal muscle injury.
A total of 168 male Sprague-Dawley (SD) rats underwent 2 h of intracompartmental pressure elevation by saline infusion into the anterior compartment of the left hindlimb to establish the ACS model. ESC-MSCs were differentiated from the human embryonic stem cell (ESC) line H9. A dose of 1.2 × 10 of ESC-MSCs was intravenously injected during fasciotomy. Post-ACS assessments included skeletal edema index, serum indicators, histological analysis, apoptosis, fibrosis, regeneration, and functional recovery of skeletal muscle. Then, fluorescence microscopy was used to observe the distribution of labeled ESC-MSCs in vivo, and western blotting and immunofluorescence analyses were performed to examine macrophages infiltration in skeletal muscle. Finally, we used liposomal clodronate to deplete macrophages and reassess skeletal muscle injury in response to ESC-MSC therapy.
ESC-MSCs significantly reduced systemic inflammatory responses, ACS-induced skeletal muscle edema, and cell apoptosis. In addition, ESC-MSCs inhibited skeletal muscle fibrosis and increased regeneration and functional recovery of skeletal muscle after ACS. The beneficial effects of ESC-MSCs on ACS-induced skeletal muscle injury were accompanied by a decrease in CD86-positive M1 macrophage polarization and an increase in CD206-positive M2 macrophage polarization. After depleting macrophages with liposomal clodronate, the beneficial effects of ESC-MSCs were attenuated.
Our findings suggest that embryonic stem cell-derived mesenchymal stem cells infusion could effectively alleviate ACS-induced skeletal muscle injury, in which the beneficial effects were related to the regulation of macrophages polarization.
急性间隔综合征(ACS)是一种众所周知的肌肉骨骼损伤并发症,会导致肌肉坏死和细胞死亡。胚胎干细胞衍生的间充质干细胞(ESC-MSCs)已被证明是治疗 ACS 的一种很有前途的方法。然而,它们的有效性和潜在的保护机制尚不清楚。本研究旨在探讨 ESC-MSCs 在 ACS 诱导的骨骼肌损伤中的疗效和潜在机制。
168 只雄性 Sprague-Dawley(SD)大鼠通过在左后肢前间隔内输注盐水来升高腔内压力 2 小时,以建立 ACS 模型。ESC-MSCs 是从人胚胎干细胞(ESC)系 H9 中分化而来的。在筋膜切开术中静脉注射 1.2×10 ESC-MSCs。ACS 后评估包括骨骼肌水肿指数、血清指标、组织学分析、细胞凋亡、纤维化、再生和骨骼肌功能恢复。然后,使用荧光显微镜观察标记的 ESC-MSCs 在体内的分布,并进行 Western blot 和免疫荧光分析,以检测骨骼肌中巨噬细胞的浸润。最后,我们使用脂质体氯膦酸盐耗竭巨噬细胞,并重新评估 ESC-MSC 治疗对骨骼肌损伤的反应。
ESC-MSCs 显著降低了全身炎症反应、ACS 引起的骨骼肌水肿和细胞凋亡。此外,ESC-MSCs 抑制了 ACS 后骨骼肌纤维化,并增加了骨骼肌的再生和功能恢复。ESC-MSCs 对 ACS 引起的骨骼肌损伤的有益作用伴随着 CD86 阳性 M1 巨噬细胞极化的减少和 CD206 阳性 M2 巨噬细胞极化的增加。用脂质体氯膦酸盐耗竭巨噬细胞后,ESC-MSCs 的有益作用减弱。
我们的研究结果表明,胚胎干细胞衍生的间充质干细胞输注可有效缓解 ACS 引起的骨骼肌损伤,其有益作用与调节巨噬细胞极化有关。